Immunotherapy After Surgery Helps People With High-Risk Bladder Cancer Live Cancer-Free LongerferomicsJan 221 min readNATIONAL. INSTITUTES OF HEALTH (NIH)By: Merck in collaboration with NCILink to Article
Novel CAR T cell therapy obe-cel demonstrates high response rates in adult patients with advanced B-cell ALLMD ANDERSON CANCER CENTER By: University of Texas MD Anderson Cancer Center Researchers Link to Article
Experimental CAR T-Cell Therapy Shrinks Tumors in Children with Deadly Brain CancerNATIONAL. INSTITUTES OF HEALTH (NIH) By: Crystal L. Mackall, M.D., Michelle Monje, M.D., Ph.D. Link to Article
Long-term Metastatic Melanoma Survival Dramatically Improves on ImmunotherapyWEILL CORNELL MEDICINE By: Dr. Jedd Wolchok Link to Article
Comments